The Patent Finder

Recombinantly Produced Neutral Protease Originating from Paenibacillus Polymyxa

Roche Diagnostics Operations, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 14/592,969, filed Jan 9, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,526,594Recombinantly Produced Neutral Protease Originating from Paenibacillus Polymyxa
In force
 · Medium confidence
Roche Diagnostics Operations, Inc.In force
Medium confidence
US 10,889,809Methods of Recombinantly Producing Neutral Protease Originating from Paenibacillus Polymyxa
In force
 · Medium confidence
Roche Diagnostics Operations, Inc.In force
Medium confidence
US 11,542,489An Expression Vector Encoding a Paenibacillus Polymxa Neutral Protease
In force
 · Medium confidence
Roche Diagnostics Operations, Inc.In force
Medium confidence
US 12,234,491Methods of Recombinantly Producing Neutral Protease Originating from Paenibacillus Polymxa
In force
 · Medium confidence
Roche Diagnostics Operations, Inc.In force
Medium confidence
Application 14/592,969Recombinantly Produced Neutral Protease Originating from Paenibacillus Polymyxa
Abandoned
Abandoned Nov 15, 2016
Roche Diagnostics Operations, Inc.AbandonedAbandoned Nov 15, 2016
Application 16/355,259Methods of Recombinantly Producing Neutral Protease Originating from Paenibacillus Polymyxa
Abandoned
Abandoned Nov 21, 2021
Roche Diagnostics Operations, Inc.AbandonedAbandoned Nov 21, 2021
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Roche Diagnostics Operations, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited